Bloodspot 17a-hydroxyprogesterone, plasma cortisol, plasma sodium and urinary 17a-hydroxyprogesterone, cortisol, sodium and creatinine levels were determined in 24 term and 32 pre-term infants on the third, eighth and fourteenth days of life. Pre-term infants, whether 'well' or 'sick', had significantly raised bloodspot 17a-hydroxyprogesterone levels (up to 158 nmol/L) compared with those found in term infants (up to 18·8 nmol/L). Urinary 17a-hydroxyprogesteronel creatinine ratios were also higher in pre-term infants. Plasma cortisol results showed similar ranges for term and pre-term infants, and bloodspot 17ahydroxyprogesterone/plasma cortisol ratios for day 3 specimens correlated with the degree of prematurity. These results may be due either to immature enzyme systems in the pre-term baby or to an excess of related steroids cross-reacting in the 17a-hydroxyprogesterone assay.
It is widely accepted that bloodspot or plasma 17a-hydroxyprogesterone (170HP) measurements afford the most convenient means of identifying deficiencies of the adrenal enzyme 21-hydroxylase (E.C. 1.1.1. 151) which account for approximately 95% of all cases of congenital adrenal hyperplasia (CAH).1 Requests for 170HP analysis in pre-term babies with hyponatraemia are not uncommon, and there is evidence that 170HP levels may be considerably elevated in some of these infants in the absence of CAH, leading to a possibility of misdiagnosis.P? Plasma cortisol levels in preterm infants are not always raised when 170HP results are high." although there are few reports of the trend in 170HP or cortisol levels in pre-term infants over the first weeks of life. In view of this, it was decided to investigate the levels of bloodspot 170HP, plasma cortisol, urinary 'free' cortisol and 170HP, and plasma Correspondence: Dr P Wood, Department of Chemical Pathology, Level D, South Pathology Block, Southampton General Hospital, Tremona Road, Southampton S09 4XY, UK. 546 and urine sodium levels in 'well' or 'ill' term and pre-term babies on the third, eighth and fourteenth days of life.
Patients and methods
Bloodspots, heparinised blood (0,5 mL) and urine specimens were collected from 24 term and 32 pre-term neonates classified into six categories (Table 1) on days 3, 8 and 14 after delivery. Neonates were defined as 'sick' if they were having or had had major abdominal surgery, had cardiac anomalies or were on assisted ventilation.
Wherever possible, blood samples were taken at the time of sampling for routine biochemical tests, and the study protocol was approved by the Ethical Committee, Southampton General Hospital. In someinstances, it was not possible to obtain a complete set of blood and urine specimens; for example, if the infant was too ill, or if a 'well' baby was not being bled for routine tests.
Bloodspot 170HP, plasma cortisol and urinary 'free' cortisol were measured by radio- 
Pre-term sick 1·S-2·5 1·9 (1'S-2'4) <37 7 5
Pre-term well <1·5 1·2 (0,9-1·4) <37 7 6
Pre-term sick <1·5 1·0 (0,9-1,3) <37 7
immunoassay (RIA) with [ 1251] tracers according to published methods.v" Urinary 170HP levels were determined by RIA after extraction into a petroleum ether (4G-60°): diethyl ether mixture (1:1, v:v). Between-batch precision for these four RIAs ranged from 6·2-14·9% (plasma cortisol), 5'7-10% (urine cortisol), 15-17% (bloodspot 170HP) and 6-15% (urine 170HP).
The main cross-reactivities of the 170HP antiserum were with 17a-hydroxypregnenolone (19·6%), progesterone (2·4%), 11 deoxycortisol (1·4%), 5a-pregnanedione (0·9%), 5(3 pregnanedione (0'3%), and cortisol «0'1%). Crossreactivities of the cortisol antiserum were 11-deoxycortisol (4·5%), 170HP (2·4%), corticosterone (1·9%), cortisone (1'2%) and progesterone «0,1%).
Plasma and urinary sodium levels were measured on an I.L. 343 flame photometer with lithium internal standardisation and urine creatinine levels were determined by the alkaline picrate reaction on an LKB 2086 reaction rate analyser. Statistical analysis of results was performed using the non-parametric Mann-Whitney U test. Probability values (two-tailed) of less than 5% (P<0·05) were considered significant.
Results
The greatest differences in bloodspot 170HP levels were seen for pre-term infants compared with term infants, whether 'well' or 'ill' (Fig. 1 ). Increases in pre-term infants were greatest on day 3 and there was a fall in mean levels on days 8 and 14, although this falling trend was not seen in all babies. Bloodspot 170HP ranges for 'well' or 'ill' infants in the same birthweight groups were significantly different for Groups 3 and 4 on days, 3, 8 and 14 and for Groups 1 and 2 on day 8: these differences were generally smaller than those seen between term and pre-term infants. No significant differences were seen between Groups 5 and 6.
In contrast to the findings for bloods pot 170HP, plasma cortisol levels did not differ greatly between 'term' and 'pre-term' infants: a significant difference was found only between Groups 1 and 4 on day 3 (0,05> P> 0,02). However, plasma cortisol results were significantly higher in 'ill' pre-term infants (Group 4) compared with 'well' pre-term infants (Group 3) on day 3 (0,01> P> 0,001).
When bloodspot 170HP and plasma cortisol results were compared, a striking difference between correlations for term and pre-term infants was observed ( Fig. 2) . Although the range of cortisol levels in the two groups was similar, much higher bloodspot 170HP concentrations were seen in the pre-term infants. To examine this observation in more detail, bloodspot 170HP/piasma cortisol ratios were plotted against gestational age at birth for day 3 specimens on all neonates for which both results were available ( Fig. 3) . A highly significant negative correlation was found by least squares regression analysis (r=0·772; P<O·OOI).
Urinary 170HP/creatinine results showed a similar pattern to bloodspot 170HP levels, with significant increases in pre-term infants on days 3 and 8 ( Fig. 4a ). Results for urinary cortisol/ creatinine ratios were not significantly different for term and pre-term infants (Fig. 4b) .
Plasma sodium levels (not shown) did not differ significantly between term and pre-term infants or between 'sick' and 'well' infants of similar birthweight: the lowest sodium level found was 123 mrnol/L for a pre-term infant (Group 5) and no very low levels (less than 120 mmol/L) were seen. Urinary sodium/creatinine ratios were significantly higher in pre-term infants on day 3, but thereafter no significant differences were found.
Discussion
It is clear from this study that bloodspot 170HP levels were markedly raised in pre-term infants. 
Interpretation of bloodspot 170HP 549
Results in term babies, whether 'well' or 'ill', were always below 20 nrnol/L, whereas levels of up to 158 nmol/L were found in pre-term babies in the absence of CAH. Although day 14 results tended to be lower than those on day 3 or 8, bloodspot 170HP concentrations of up to 70 nmol/L blood were still observed in some pre-term neonates. High blood 170HP levels in pre-term infants have been reported in other studies and are the main cause of high 're-test' levels in screening programmes. 2--4, 9, 10 In a previous study" we examined bloodspots from 491 babies, including pre-term infants, and established an upper limit of normal (99·9 centile) of 64 nmol/L blood. This, 'composite' cut-off level is unsatisfactory, however, since it is inappropriately high for term infants with the possibility of generating a 'false negative' result. Conversely, pre-term infants could be misdiagnosed as having CAH using this upper limit: levels greater than 64 nmol/L were seen in this study in 11 pre-term infants on day 3, four infants on day 8 and one infant on day 14. The awareness of two separate reference ranges for term and pre-term infants, therefore, is essential for the correct interpretation of bloodspot 170HP results. The cause of high blood 170HP levels in pre-term infants has still to be established. Although blood progesterone concentrations in infants are high, shortly after birth they decrease rapidly!' and possible cross-reactivity problems are unlikely. Our data suggest that, although there is no difference in plasma cortisol levels achieved by term or pre-term infants, in the latter group cortisol production is accompanied by much larger increases in 170HP radioimmunoassay results. The extent of 170HP 'overproduction' as measured by bloodspot 170HP/piasma cortisol ratios showed a significant negative correlation with gestational age at birth. This effect could result from at least two mechanisms: firstly, the adrenal enzyme pathway for cortisol synthesis may be immature in pre-term infants, so that cortisol is synthesised at the expense of a relatively large 170HP production. Secondly, it is possible that steroids closely related to 170HP, and cross-reacting in the 170HP radioimmunoassay, may be produced by the adrenals of pre-term infants. The contribution to steroid production by the foetal adrenal zone, which synthesises a distinct spectrum of steroids.P may be considerable in premature babies. On the present evidence it is not possible to distinguish between these two possibilities. Plasma cortisol levels in pre-term infants were not found to be lower than those in term infants in this study: levels varied from low to moderately high in both term and pre-term infants, and urinary 'free' cortisol/creatinine ratios did not differ for the two groups. We have no evidence, therefore, that levels of corticosteroid binding globulin (CBG) may be lower in pre-term infants as suggested by Murphy et ai. 5 Plasma sodium levels showed little change between term and pre-term infants and, although there was evidence of higher urinary sodium/creatinine ratios in pre-term infants on day 3 (0-05> P> 0,02), this was not seen by day 8 at a time when bloodspot 170HP levels were often markedly elevated. Although a weak positive correlation was observed between bloodspot 170HP concentrations and urinary sodium/creatinine ratios (r=0·312 0·01> P> 0,001), urinary sodium creatinine ratios for bloodspot 170HP levels in excess of 20 nrnol/L ranged from 1 to 127 nmol/rnmol creatinine. There was no strong correlation, therefore, between salt loss and bloodspot 170HP level. A negative sodium balance has been observed in immature and sick infants, possibly due to immaturity of distal tubular function.
In conclusion, it is suggested that bloodspot 170HP levels in neonates should be interpreted using different 'cut-off limits for term and pre-term infants. For our laboratory an upper limit of normal for day 8 bloodspots of 20 nmol/L is appropriate for term infants, whereas a level of up to 200 nmoVL in a pre-term infant should not be assumed to be evidence of CAH without further investigation. Confirmation of CAH in both term and pre-term babies can be obtained by re-testing for bloodspot or plasma 170HP levels and by urinary steroid profile analysis to confirm the site of the enzyme block. It is important that laboratories undertaking 170HP measurements for the diagnosis of CAH determine appropriate 'term' and 'pre-term' reference ranges with their own methods.
